Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02755103 · ClinicalTrials.gov registry record · NA
Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD
A NA study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT02755103 is a NA study of Stress Disorders, Post-Traumatic and Substance-Related Disorders that has completed, run by Medical University of South Carolina. The registered enrollment target is 90 participants, below the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02755103, a NA study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study will modify an already existing therapy for individuals with substance use disorders to address Post Traumatic Stress Disorder (PTSD) in women enrolled in substance use disorders (SUD) treatment who suffer with both PTSD and SUD. Mindfulness meditation has been shown to help individuals to cope with stress and regulate emotions. Through meditation practice women will experience less distress related to PTSD symptoms and reduced substance use in response to emotional triggers. Women enrolled in intensive SUD treatment at a community program will be randomized to receive either 8 weeks of 90 minute Mindfulness Based Relapse Prevention (MBRP) group sessions plus treatment as usual (TAU) or TAU alone. The MBRP group sessions will replace 90 minutes of TAU group therapy. Measures of feasibility of implementation, acceptance and adherence will be obtained. Preliminary efficacy for substance use and PTSD symptom severity will be measured at post treatment and at 3- and 6- months' follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness Based Relapse Prevention (MBRP)
Study Locations (1)
South Carolina
- The Charleston Center - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02755103
The ClinicalTrials.gov registry entry for NCT02755103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (42% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness Based Relapse Prevention (MBRP) is the first listed.
NCT02755103 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT02755103 about?
NCT02755103 is a clinical study titled "Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD". The current study will modify an already existing therapy for individuals with substance use disorders to address Post Traumatic Stress Disorder (PTSD) in women enrolled in substance use disorders (SUD) treatment who suffer with both PTSD and SUD. Mindfulness meditation has been shown to help indivi...
What is the current status of trial NCT02755103?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2016-06-01. Estimated completion is 2021-10-01.
What conditions does trial NCT02755103 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Substance-Related Disorders.
What interventions are being tested in trial NCT02755103?
The interventions under investigation include: Mindfulness Based Relapse Prevention (MBRP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02755103?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02755103 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Explore more on PlainTrial
Stress Disorders, Post-Traumatic
All registered trials for this condition
Substance-Related Disorders
All registered trials for this condition
South Carolina
All trials with a study site in South Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.